Joint association of patients' sex and PD-L1 expression with overall survival benefits and tumor-immune microenvironment in immune checkpoint inhibitors for cancers.
Anlin LiYongjian ChenWenda ZhangHaitao ZhongQiyun OuYang GuJunqing XiaDagui LinTuping FuRuixin LiuHai HuYunfang YuHe-Rui YaoPublished in: Clinical and translational medicine (2020)